Cognex (NASDAQ:CGNX) Stock Rating Upgraded by JPMorgan Chase & Co.

Cognex (NASDAQ:CGNX) was upgraded by equities research analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a research report issued to clients and investors on Tuesday. The brokerage currently has a $75.00 price target on the scientific and technical instruments company’s stock. JPMorgan Chase & Co.‘s target price points to a potential upside of 13.48% from the stock’s current price.

Several other analysts also recently commented on CGNX. Raymond James Financial reaffirmed a “strong-buy” rating on shares of Cognex in a research note on Thursday, February 12th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $63.00 price objective on shares of Cognex in a research note on Friday, February 13th. KeyCorp reaffirmed an “overweight” rating and set a $70.00 price objective (up from $50.00) on shares of Cognex in a research note on Friday, February 13th. Barclays reaffirmed an “overweight” rating and set a $75.00 price objective (up from $64.00) on shares of Cognex in a research note on Monday, May 11th. Finally, The Goldman Sachs Group reaffirmed a “buy” rating and set a $80.00 price objective (up from $70.00) on shares of Cognex in a research note on Monday, May 11th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $70.43.

Cognex Stock Performance

Shares of CGNX opened at $66.09 on Tuesday. The firm has a market capitalization of $11.00 billion, a price-to-earnings ratio of 78.68 and a beta of 1.48. The business’s fifty day moving average price is $55.58 and its two-hundred day moving average price is $46.82. Cognex has a 52 week low of $29.00 and a 52 week high of $71.90.

Cognex (NASDAQ:CGNX) last posted its quarterly earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.09. Cognex had a return on equity of 10.89% and a net margin of 13.62%.The business had revenue of $268.44 million for the quarter, compared to analyst estimates of $245.98 million. During the same period last year, the company earned $0.14 EPS. The firm’s revenue was up 24.3% on a year-over-year basis. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. As a group, research analysts forecast that Cognex will post 1.4 EPS for the current year.

Insider Transactions at Cognex

In related news, VP Laura Ann Macdonald sold 98,122 shares of Cognex stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $66.80, for a total transaction of $6,554,549.60. Following the completion of the transaction, the vice president owned 5,258 shares in the company, valued at approximately $351,234.40. This trade represents a 94.91% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Mark Fennell sold 64,873 shares of the business’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $67.05, for a total value of $4,349,734.65. Following the sale, the insider owned 11,263 shares of the company’s stock, valued at approximately $755,184.15. This represents a 85.21% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 204,595 shares of company stock valued at $13,631,580 in the last quarter. 1.70% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Cognex

A number of hedge funds and other institutional investors have recently made changes to their positions in CGNX. Northwestern Mutual Wealth Management Co. raised its position in shares of Cognex by 173,138.2% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 10,477,448 shares of the scientific and technical instruments company’s stock valued at $376,979,000 after buying an additional 10,471,400 shares in the last quarter. Norges Bank acquired a new stake in shares of Cognex in the fourth quarter valued at approximately $73,103,000. Alyeska Investment Group L.P. acquired a new stake in shares of Cognex in the fourth quarter valued at approximately $68,388,000. AQR Capital Management LLC raised its position in shares of Cognex by 18,810.9% in the second quarter. AQR Capital Management LLC now owns 1,794,649 shares of the scientific and technical instruments company’s stock valued at $56,657,000 after buying an additional 1,785,159 shares in the last quarter. Finally, Pictet Asset Management Holding SA raised its position in shares of Cognex by 27.9% in the fourth quarter. Pictet Asset Management Holding SA now owns 7,013,184 shares of the scientific and technical instruments company’s stock valued at $252,360,000 after buying an additional 1,529,010 shares in the last quarter. 88.12% of the stock is currently owned by institutional investors and hedge funds.

About Cognex

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.